Mitochondrial Energy Metabolism in Burns (Mito Burn)

The Role of the Mitochondrian in the Metabolic Stress Response to Burn Trauma

The goal of this observational study is to assess the impact of burn injury on cellular energetics in patients that have been admitted to the burn center at Arkansas Children's Hospital for burn care and require one or more procedures to clean, debride, and repair burn wounds will be eligible to participate in this study.

During the study, we will collect the following information:

  • General background information such as date of birth, height, weight, and other basic information.
  • Medical information, such as: basic medical information, details of burn injury, vital signs on the day of surgery, medicines you take during your stay, and some clinical tests.
  • Blood, urine, and tissue during surgeries you have during your stay.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

125

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Arkansas
      • Little Rock, Arkansas, United States, 72202
        • Recruiting
        • Arkansas Children's Hospital
        • Principal Investigator:
          • Craig Porter, PhD
        • Sub-Investigator:
          • Esther Teo, MD
        • Sub-Investigator:
          • Robert Maxson, MD
        • Sub-Investigator:
          • Richard Yeager, MD
        • Sub-Investigator:
          • Daniel Lozano, MD
        • Sub-Investigator:
          • Mandy Yelvington, MS, OTR/L

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Up to 125 patients (2 years to 80 years old) will be enrolled in this study. We will recruit both males and females requiring hospital admission to the ACH burn unit for burn care.

Description

Inclusion Criteria:

  • Male or Female
  • Ages 2 years to 80 years
  • Requiring hospital admission for burn care
  • All races
  • All ethnicities

Exclusion Criteria:

  • Age < 2 years
  • Under 10 kg in body mass
  • Age > 80 years
  • Active pregnancy
  • Unable to provide informed consent and no legal authorized representative present
  • Patient is considered moribund at the time of admission by the treating physician.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood Bioenergetics
Time Frame: Through study completion, an average of 1 year
Peripheral Blood Mononuclear Cell (PBMC) respiration
Through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood metabolics signatures
Time Frame: Through study completion, an average of 1 year
Peripheral Blood Mononuclear Cell (PBMC) respiration
Through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Craig Porter, PhD, Arkansas Children's Research Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 20, 2023

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

August 10, 2023

First Submitted That Met QC Criteria

June 9, 2026

First Posted (Actual)

June 11, 2026

Study Record Updates

Last Update Posted (Actual)

June 11, 2026

Last Update Submitted That Met QC Criteria

June 9, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 263136

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burn Injury

Subscribe